ArticleInsights into imaging2026
Fetal MRI: abdominal cystic lesions.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fetal MRI has become an essential tool for evaluating abdominal cystic lesions detected on prenatal ultrasound, offering superior soft tissue contrast and multiplanar imaging capabilities. This observational case series, conducted at Quironsalud Madrid University Hospital, analyzed fetuses diagnosed with abdominal cystic lesions who underwent fetal MRI. Lesions were classified into gastrointestinal, genitourinary, teratomatous, and syndromic categories. Fetal MRI allowed for precise lesion characterization, differentiating cystic masses from solid or mixed lesions, and identifying associated structural abnormalities. MRI findings were correlated with fetal ultrasound and, when available, postnatal imaging or surgical outcomes, demonstrating complementary information and improved diagnostic confidence compared to ultrasound alone. This improved accuracy has direct clinical implications, aiding in prenatal counseling, optimizing perinatal management, and guiding postnatal surgical planning. Our results reinforce the role of fetal MRI as a complementary imaging modality for refining the diagnosis of congenital abdominal cystic lesions and improving neonatal outcomes. CRITICAL RELEVANCE STATEMENT: This article critically evaluates the role of fetal MRI, in conjunction with prenatal ultrasound, in characterizing abdominal cystic lesions, highlighting its diagnostic advantages over ultrasound and its clinical impact on prenatal counseling, perinatal management, and postnatal surgical planning in radiological practice. KEY POINTS: Abdominal cystic lesions are frequently detected on prenatal ultrasound, but their characterization and differentiation remain challenging. Fetal MRI characterizes lesions, assesses their extent, improves classification and diagnosis, and offers superior soft tissue contrast for evaluating complex anomalies. Fetal MRI complements prenatal ultrasound, allowing a more precise assessment of lesion characteristics and facilitating prenatal counseling and perinatal planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.